NCT04262804 2023-08-22A Study to Evaluate the Efficacy and Safety of Margetuximab Plus Chemotherapy in the Treatment of Chinese Patients With HER2+ MBCZai Lab (Hong Kong), Ltd.Phase 2 Unknown123 enrolled